Agreed. But is there reason to believe that blocking cytokines will block the large vessel inflammation?
I'd actually be a little concerned if Veyonda's actions were too broad, as it would greatly increase the risk of unwanted effects. I'll quite happily settle for it nullifying the "cytokine storm" of septic shock.
- Forums
- ASX - By Stock
- NOX
- Recent developments
Recent developments, page-2
Featured News
Add NOX (ASX) to my watchlist
(20min delay)
|
|||||
Last
11.0¢ |
Change
0.005(4.76%) |
Mkt cap ! $32.14M |
Open | High | Low | Value | Volume |
11.5¢ | 11.5¢ | 11.0¢ | $18.94K | 171.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 50000 | 11.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
12.5¢ | 66800 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 100532 | 0.105 |
6 | 393641 | 0.100 |
1 | 53000 | 0.096 |
1 | 20000 | 0.095 |
1 | 100000 | 0.092 |
Price($) | Vol. | No. |
---|---|---|
0.125 | 66800 | 1 |
0.130 | 131463 | 3 |
0.135 | 30000 | 1 |
0.140 | 39486 | 2 |
0.145 | 100000 | 1 |
Last trade - 14.48pm 08/11/2024 (20 minute delay) ? |
Featured News
NOX (ASX) Chart |
The Watchlist
EQN
EQUINOX RESOURCES LIMITED.
Zac Komur, MD & CEO
Zac Komur
MD & CEO
SPONSORED BY The Market Online